COVID-19
“I want to apologize for advocating for the use of masks” – Spread of respiratory illnesses not slowed down by mask use

The study examines the effectiveness of masks and of following a hand hygiene program in reducing the likelihood of acquiring respiratory virus infections such as COVID-19.
British Health Researcher Dr. John Campbell shares the disappointing results in this presentation:
From Dr. John Campbell
From the Cochrane Library
What did we do?
We searched for randomised controlled studies that looked at physical measures to stop people acquiring a respiratory virus infection.
We were interested in how many people in the studies caught a respiratory virus infection, and whether the physical measures had any unwanted effects.
What did we find?
We identified 78 relevant studies. They took place in low‐, middle‐, and high‐income countries worldwide: in hospitals, schools, homes, offices, childcare centres, and communities during non‐epidemic influenza periods, the global H1N1 influenza pandemic in 2009, epidemic influenza seasons up to 2016, and during the COVID‐19 pandemic. We identified five ongoing, unpublished studies; two of them evaluate masks in COVID‐19. Five trials were funded by government and pharmaceutical companies, and nine trials were funded by pharmaceutical companies.
We assessed the effects of:
· medical or surgical masks;
· N95/P2 respirators (close‐fitting masks that filter the air breathed in, more commonly used by healthcare workers than the general public); and
· hand hygiene (hand‐washing and using hand sanitiser).
We obtained the following results:
Medical or surgical masks
Ten studies took place in the community, and two studies in healthcare workers. Compared with wearing no mask in the community studies only, wearing a mask may make little to no difference in how many people caught a flu‐like illness/COVID‐like illness (9 studies; 276,917 people); and probably makes little or no difference in how many people have flu/COVID confirmed by a laboratory test (6 studies; 13,919 people). Unwanted effects were rarely reported; discomfort was mentioned.
N95/P2 respirators
Four studies were in healthcare workers, and one small study was in the community. Compared with wearing medical or surgical masks, wearing N95/P2 respirators probably makes little to no difference in how many people have confirmed flu (5 studies; 8407 people); and may make little to no difference in how many people catch a flu‐like illness (5 studies; 8407 people), or respiratory illness (3 studies; 7799 people). Unwanted effects were not well‐reported; discomfort was mentioned.
Hand hygiene
Following a hand hygiene programme may reduce the number of people who catch a respiratory or flu‐like illness, or have confirmed flu, compared with people not following such a programme (19 studies; 71,210 people), although this effect was not confirmed as statistically significant reduction when ILI and laboratory‐confirmed ILI were analysed separately. Few studies measured unwanted effects; skin irritation in people using hand sanitiser was mentioned.
Dr. John Campbells presentation notes with links:
RCTs did not show a clear reduction in respiratory viral infection with the use of medical/surgical masks.
There were no clear differences between the use of medical/surgical masks compared with N95/P2 respirators in healthcare workers, when used in routine care to reduce respiratory viral infection.
Do physical measures such as hand-washing or wearing masks stop or slow down the spread of respiratory viruses?
https://www.cochranelibrary.com/cdsr/…
Evidence published up to October 2022.
Background Influenza (H1N1) caused by the H1N1pdm09 virus in 2009
Severe acute respiratory syndrome (SARS) in 2003 Coronavirus disease 2019 (COVID-19)
Update of a Cochrane Review last published in 2020.
We include results from studies from the current COVID-19 pandemic.
Main results 11 new RCTs and cluster-RCTs n = 610,872
Bringing the total number of RCTs to 78
Medical/surgical masks compared to no masks
Wearing masks in the community probably makes little or no difference to the outcome of influenza‐like illness
wearing a mask may make little to no difference in how many people caught a flu-like illness/COVID-like illness
Risk ratio (RR) 0.95, (0.84 to 1.09) 9 trials, n = 276,917 participants
Moderate-certainty evidence.
Wearing masks in the community probably makes little or no difference to the outcome of laboratory-confirmed influenza/SARS-CoV-2 RR 1.01, (CI 0.72 to 1.42)
6 trials, n = 13,919 Moderate-certainty evidence
Harms were rarely measured and poorly reported (very low-certainty evidence).
N95/P2 respirators compared to medical/surgical masks
We pooled trials comparing N95/P2 respirators with medical/surgical masks
We are very uncertain on the effects of N95/P2 respirators compared with medical/surgical masks on the outcome of clinical respiratory illness
Compared with wearing medical or surgical masks, wearing N95/P2 respirators probably makes little to no difference in how many people have confirmed flu and may make little to no difference in how many people catch a flu-like illness, or respiratory illness.
Confirmed influenza RR 0.70, (0.45 to 1.10) N = 7,779 Very low-certainty evidence
Influenza like illness N95/P2 respirators compared with medical/surgical masks may be effective for ILI RR 0.82 N= 8,407 Low-certainty evidence
The use of a N95/P2 respirators compared to medical/surgical masks
Probably makes little or no difference for laboratory-confirmed influenza infection RR 1.10 N = 8,407 Moderate-certainty evidence
Restricting pooling to healthcare workers made no difference to the overall findings.
Harms were poorly measured and reported
Discomfort wearing medical/surgical masks or N95/P2 respirators was mentioned in several studies
Very low-certainty evidence
One new RCT Medical/surgical masks were non-inferior to N95 respirators N = 1,009 healthcare workers in four countries, providing direct care to COVID-19 patients.
Business
Conservatives demand probe into Liberal vaccine injury program’s $50m mismanagement

From LifeSiteNews
The Liberals’ Vaccine Injury Support Program is accused of mismanaging a $50-million contract with Oxaro Inc. and failing to resolve claims for thousands of vaccine-injured Canadians.
Conservatives are calling for an official investigation into the Liberal-run vaccine injury program, which has cost Canadians millions but has little to show for it.
On July 14th, four Conservative Members of Parliament (MPs) signed a letter demanding answers after an explosive Global News report found the Liberals’ Vaccine Injury Support Program (VISP) misallocated taxpayer funds and disregarded many vaccine-injured Canadians.
“The federal government awarded a $50 million taxpayer-funded contract to Oxaro Inc. (formerly Raymond Chabot Grant Thornton Consulting Inc.). The purpose of this contract was to administer the VISP,” the letter wrote.
“However, there was no clear indication that Oxaro had credible experience in healthcare or in the administration of health-related claims raising valid questions about how and why this firm was selected,” it continued.
Canada’s VISP was launched in December 2020 after the Canadian government gave vaccine makers a shield from liability regarding COVID-19 jab-related injuries.
However, mismanagement within the program has led to many injured Canadians still waiting to receive compensation, while government contractors grow richer.
“Despite the $50 million contract, over 1,700 of the 3,100 claims remain unresolved,” the Conservatives continued. “Families dealing with life-altering injuries have been left waiting years for answers and support they were promised.”
Furthermore, the claims do not represent the total number of Canadians injured by the allegedly “safe and effective” COVID shots, as inside memos have revealed that the Public Health Agency of Canada (PHAC) officials neglected to report all adverse effects from COVID shots and even went as far as telling staff not to report all events.
The PHAC’s downplaying of vaccine injuries is of little surprise to Canadians, as a 2023 secret memo revealed that the federal government purposefully hid adverse effect so as not to alarm Canadians.
Of the $50.6 million that Oxaro Inc., has received, $33.7 million has been spent on administrative costs, compared to only $16.9 million going to vaccine-injured Canadians.
The letter further revealed that former VISP employees have revealed that the program lacked professionalism, describing what Conservatives described as “a fraternity house rather than a professional organization responsible for administering health-related claims.”
“Reports of constant workplace drinking, ping pong, and Netflix are a slap in the face to taxpayers and the thousands of Canadians waiting for support for life altering injuries,” the letter continued.
Regardless of this, the Liberal government, under Prime Minister Mark Carney, is considering renewing its contract with Oxaro Inc.
Indeed, this would hardly be the first time that Liberals throw taxpayer dollars at a COVID program that is later exposed as ineffective and mismanaged.
Canada’s infamous ArriveCan app, which was mandated for all travelers in and out of Canada in 2020, has cost Canadians $54 million, despite the Public Health Agency of Canada admitting that they have no evidence that the program saved lives.
Details regarding the app and the government contracts surrounding it have been hidden from Canadians, as Liberals were exposed in 2023 for hiding a RCMP investigation into the app from auditors.
An investigation of the ArriveCan app began in 2022 after the House of Commons voted 173-149 for a full audit of the controversial app.
COVID-19
Trump DOJ dismisses charges against doctor who issued fake COVID passports

From LifeSiteNews
Attorney General Pam Bondi has ended the federal prosecution of Dr. Michael Kirk Moore for giving ‘patients a choice when the federal government refused to do so.’
The Utah plastic surgeon who issued fake COVID-19 vaccine passports to help patients get around COVID vaccine mandates will no longer be prosecuted, U.S. Attorney General Pam Bondi announced Saturday.
During the COVID pandemic, Dr. Michael Kirk Moore Jr. and employees at his Salt Lake private practice developed a plan to provide patients who objected to being forced to take the vaccine with ineffectual, harmless saline injections instead and give them COVID vaccination cards that would satisfy (since rescinded) mandates to take the shot as a condition of employment, public facilities, mass gatherings, and more.
For his efforts, he was indicted for allegedly “endanger[ing] the health and well-being of a vulnerable population” and “undermin[ing] public trust and the integrity of federal health care programs.” The government also accused him of doing so for profit, but several sources attested off the record that Moore not only issued the cards for free but actually refused offers of compensation.
“They broke no laws and harmed no person,” the defendants’ legal team said in 2023. “Dr. Moore, specifically, abided by his long held Hippocratic oath to First Do No Harm. We believe he and his co-defendants will be found innocent of all charges.”
Last month, LifeSiteNews reported that Moore’s trial was set to begin on July 7, which could have potentially ended with him facing 35 years in jail and a $125,000 penalty. Supporters of the doctor had expressed worry that the change in presidential administration had not yet halted the prosecution.
Over the weekend, however, Bondi announced that at her direction it has now done exactly that.
“Dr. Moore gave his patients a choice when the federal government refused to do so,” she said. “He did not deserve the years in prison he was facing. It ends today.”
There is a large body of warning signs against the shots, which were developed in record time by the first Trump administration’s Operation Warp Speed initiative.
The federal Vaccine Adverse Event Reporting System (VAERS) reports 38,709 deaths, 221,030 hospitalizations, 22,331 heart attacks, and 28,966 myocarditis and pericarditis cases as of June 27, among other ailments. U.S. Centers for Disease Control & Prevention (CDC) researchers have recognized a “high verification rate of reports of myocarditis to VAERS after mRNA-based COVID-19 vaccination,” leading to the conclusion that “under-reporting is more likely” than over-reporting.
An analysis of 99 million people across eight countries published in the journal Vaccine “observed significantly higher risks of myocarditis following the first, second and third doses” of mRNA-based COVID vaccines, as well as signs of increased risk of “pericarditis, Guillain-Barré syndrome, and cerebral venous sinus thrombosis,” and other “potential safety signals that require further investigation.”
In April 2024, the U.S. Centers for Disease Control & Prevention (CDC) was forced to release by court order 780,000 previously undisclosed reports of serious adverse reactions, and a study out of Japan found “statistically significant increases” in cancer deaths after third doses of mRNA-based COVID-19 vaccines, and offered several theories for a causal link.
In January, a long-awaited Florida grand jury report on the COVID vaccine manufacturers found that while only a miniscule percentage of the millions of vaccinations resulted in serious harm based on the data it had access to, such events do occur, and there are “profound and serious issues” in pharmaceutical companies’ review process, including reluctance to share what evidence of adverse events they did find.
In May, Trump administration U.S. Food & Drug Administration (FDA) Commissioner Dr. Marty Makary and vaccine chief Dr. Vinay Prasad announced that there would no longer be blanket recommendations for all Americans to receive the shot, but the “risk factors” it would still be recommended for include asthma, cancer, cerebrovascular disease, chronic kidney diseases, a handful of chronic liver and lung diseases, diabetes, disabilities such as Down’s syndrome, heart conditions, HIV, dementia, Parkinson’s, obesity, smoking, tuberculosis, and more. Health & Human Services (HHS) Secretary Robert F. Kennedy Jr. subsequently announced COVID vaccines will not be recommended to healthy children or pregnant women.
The Trump administration has approved a new mRNA-based COVID-19 vaccine from Moderna, suggesting the federal government’s overall view of the shots will remain favorable, albeit without mandates of any kind. At the same time, it does require mRNA COVID shots to carry a new warning about the danger of heart damage in young men.
-
Addictions1 day ago
Why B.C.’s new witnessed dosing guidelines are built to fail
-
Frontier Centre for Public Policy2 days ago
Canada’s New Border Bill Spies On You, Not The Bad Guys
-
Business1 day ago
Carney Liberals quietly award Pfizer, Moderna nearly $400 million for new COVID shot contracts
-
Business2 days ago
Carney government should apply lessons from 1990s in spending review
-
Energy2 days ago
CNN’s Shock Climate Polling Data Reinforces Trump’s Energy Agenda
-
Business24 hours ago
Mark Carney’s Fiscal Fantasy Will Bankrupt Canada
-
Opinion1 day ago
Preston Manning: Three Wise Men from the East, Again
-
Red Deer1 day ago
Westerner Days Attraction pass and New Experiences!